<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CoValence Laboratories: Private Label and Custom Skincare / Personal Care Manufacturer &#187; OTC</title>
	<atom:link href="http://www.covalence.com/news-wire/tag/otc/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.covalence.com</link>
	<description></description>
	<lastBuildDate>Thu, 26 Jan 2012 18:52:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>OTC Manufacturing and FDA Inspections</title>
		<link>http://www.covalence.com/news-wire/otc-manufacturing-and-fda-inspections/</link>
		<comments>http://www.covalence.com/news-wire/otc-manufacturing-and-fda-inspections/#comments</comments>
		<pubDate>Thu, 08 Oct 2009 17:36:16 +0000</pubDate>
		<dc:creator>Lauren</dc:creator>
				<category><![CDATA[CoValence Specific]]></category>
		<category><![CDATA[Certificate of Analysis]]></category>
		<category><![CDATA[cGMP]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Form 482]]></category>
		<category><![CDATA[OTC]]></category>
		<category><![CDATA[SOP]]></category>

		<guid isPermaLink="false">http://www.covalence.com/?p=738</guid>
		<description><![CDATA[The OTC Department breaks down some of the process to be compliant with the FDA to offer you great OTC products. ]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal"><span>From the CoValence Laboratories OTC Department </span></p>
<p class="MsoNormal">One of the main focuses of the manufacturing department is to find the most effective processes to comply with FDA Regulations and current Good Manufacturing Practices.  We need to know what we’re doing right and wrong and, based on that information, implement Standard Operating Procedures to increase our compliance levels. This is a constant focus as every 2 – 3 years an FDA inspector arrives unannounced and delivers a Form 482 Notice of Inspection.</p>
<p style="text-align: center;"><img class="aligncenter" style="border: 1px solid black;" title="FDA" src="http://www.medcitynews.com/wordpress/wp-content/uploads/postdoc_fda_logo.jpg" alt="" width="212" height="141" /></p>
<p class="MsoNormal">
<p class="MsoNormal"><span>It is during these inspections that the culmination of these efforts are highlighted.  The first part of an inspection is usually a tour of the building from Receiving through Shipping while describing our cGMP’s throughout the tour.  It’s quite grueling to walk the entire floor describing each aspect from Receiving &amp; QC, Ingredient Storage &amp; Retrieval, Manufacturing &amp; QC, Filling &amp; QC and finally Shipping.  Once this is completed the FDA inspector has an idea of the areas he will wanted to focus on for his inspection.  We will go over a few Batch Cards from our OTC products manufactured in the past year, and over a wide variety of Standard Operating Procedures.  Documentation, Documentation, Documentation! It’s interesting that we can start with a batch card and be expected to show anything from a Certificate of Analysis, or other receiving documentation on an ingredient, to testing results for the finished product and training records for the mixer who produced the product. </span></p>
<p class="MsoNormal"><span>These inspections not only help teach us how to improve our cGMP’s for our OTC manufacturing, which naturally spill over to the cosmetic manufacturing processes by necessity, they also ensure that an outside auditing source sets a high standard for our manufacturing facility that cannot be compromised.</span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.covalence.com/news-wire/otc-manufacturing-and-fda-inspections/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Vault &#8211; May 09</title>
		<link>http://www.covalence.com/news-wire/the-vault-may-09/</link>
		<comments>http://www.covalence.com/news-wire/the-vault-may-09/#comments</comments>
		<pubDate>Tue, 19 May 2009 16:14:57 +0000</pubDate>
		<dc:creator>Lauren</dc:creator>
				<category><![CDATA[Vault]]></category>
		<category><![CDATA[Aloe gel]]></category>
		<category><![CDATA[OTC]]></category>
		<category><![CDATA[SPF]]></category>
		<category><![CDATA[Summer]]></category>
		<category><![CDATA[superlightener]]></category>

		<guid isPermaLink="false">http://www.covalence.com/?p=210</guid>
		<description><![CDATA[Summer is just around the corner. Check out our OTC offerings for Summer 2009.]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal">Summer <span>is just around the corner</span>. Keep safe from harmful rays with our Day Cream SPF 30. But if you do get caught out in the sun unprotected, our Aloe Gel<span> with 1% HC</span> is ready to help sooth inflamed skin. Superlightener <span>with 2% HQ </span>will help restore an even tone to skin hyper-pigmented by the sun’s rays.</p>
<p class="MsoNormal"> <strong>Day Cream 30 SPF (SKU# VLT0.6000G)</strong> is a lightweight hyaluronic acid infused chemical sunscreen. </p>
<p class="MsoNormal"><strong> <span style="font-weight: normal;"><strong><span>Superlightener 2%  HQ Serum (SKU# VLT0.4001G)</span></strong><span> dramatically lightens pigmentation with hydroquinone and glycolic acid.</span></span></strong></p>
<p class="BodyA"><strong><span> <span style="font-weight: normal;"><strong>Aloe Gel  1%  HC (SKU# VLT0.5301G)</strong> is a hydrocortisone calming gel with added anti-inflammatory benefits of white ginger and bisabolol.</span></span></strong></p>
<p class="MsoNormal"><span> This month’s featured products are a small snapshot of our OTC offerings. Please contact your Account Executive for minimums and pricing.</span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.covalence.com/news-wire/the-vault-may-09/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using disk: enhanced

Served from: www.covalence.com @ 2012-02-08 17:18:14 -->
